- DexCom Inc. (DXCM, Financial) promotes Jake Leach to President and Chief Operating Officer.
- Jake Leach has over 21 years of leadership experience at DexCom, contributing significantly to its biosensing platforms.
- Leach will now oversee corporate development and strategy efforts alongside his operational responsibilities.
DexCom, Inc. (DXCM), a leader in real-time continuous glucose biosensing, has announced the promotion of Jake Leach to the expanded role of President and Chief Operating Officer. Mr. Leach, who has been with DexCom for over 21 years, has played a pivotal role in steering the company's innovative biosensing platforms since its first commercial system launch.
In his previous role as Chief Operating Officer, Leach was responsible for end-to-end product development and executive leadership functions, including global operations, research and development, quality management, regulatory, and medical affairs. As President, Leach will now also oversee DexCom's corporate development and strategic initiatives.
Chairman and CEO, Kevin Sayer, expressed confidence in the appointment, stating that Mr. Leach has significantly strengthened DexCom's capability to innovate and achieve ambitious goals for the future of metabolic health. Leach himself remarked on the opportunity to tackle global health challenges while benefiting the company’s stakeholders and expressed excitement about leading the company into a promising future.
DexCom continues to empower individuals with its pioneering glucose biosensing technology, setting industry standards for over 25 years. The company remains committed to transforming diabetes management and enhancing the lives of those it serves.
